K+S AG, a well-known company in the agricultural-chemicals sector, has adjusted its full-year EBITDA expectations, now expecting results towards the lower end of its previously guided range.

This revision is due to an updated sales-volume forecast, with part of the decline being attributed to an increase in worker sickness among its German staff.

The company is facing concerns about higher absenteeism, which is a problem also experienced by other major firms, including those in the tech industry.

As K+S deals with these challenges, investors and analysts are closely monitoring the impact on productivity and overall performance.